Title | Type | SJR | H index | Total Docs. (2017) | Total Docs. (3years) | Total Refs. (2017) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2017) | %Female (2017) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Cochrane Database of Systematic Reviews | journal | 2.347 Q1 | 327 | 1348 | 4691 | 122482 | 22768 | 4653 | 4.44 | 90.86 | 48.01 | |
2 | Journal of Antimicrobial Chemotherapy | journal | 2.419 Q1 | 221 | 549 | 1671 | 17093 | 7930 | 1408 | 4.57 | 31.13 | 44.75 | |
3 | Alimentary Pharmacology and Therapeutics | journal | 3.917 Q1 | 207 | 505 | 1261 | 12656 | 5370 | 659 | 4.27 | 25.06 | 29.46 | |
4 | Rheumatology | journal | 2.344 Q1 | 198 | 396 | 1097 | 9165 | 4347 | 843 | 3.68 | 23.14 | 40.94 | |
5 | Drugs | journal | 1.547 Q1 | 188 | 163 | 472 | 11786 | 2433 | 463 | 5.16 | 72.31 | 37.54 | |
6 | Clinical Pharmacokinetics | journal | 1.482 Q1 | 184 | 122 | 301 | 6990 | 1370 | 272 | 4.16 | 57.30 | 34.03 | |
7 | British Journal of Clinical Pharmacology | journal | 1.543 Q1 | 167 | 298 | 841 | 11056 | 3196 | 731 | 3.63 | 37.10 | 39.10 | |
8 | Drug Safety | journal | 1.447 Q1 | 140 | 115 | 304 | 4725 | 1079 | 258 | 3.52 | 41.09 | 44.23 | |
9 | Orphanet Journal of Rare Diseases | journal | 1.413 Q1 | 136 | 187 | 573 | 7778 | 2226 | 567 | 3.83 | 41.59 | 51.53 | |
10 | Journal of Psychopharmacology | journal | 1.939 Q1 | 135 | 158 | 402 | 10619 | 1715 | 374 | 4.59 | 67.21 | 44.86 | |
11 | CNS Drugs | journal | 1.635 Q1 | 129 | 85 | 261 | 6852 | 1259 | 256 | 4.63 | 80.61 | 45.37 | |
12 | International Journal of Neuropsychopharmacology | journal | 1.808 Q1 | 125 | 111 | 514 | 6468 | 2277 | 502 | 4.50 | 58.27 | 39.47 | |
13 | Acta Pharmacologica Sinica | journal | 1.173 Q1 | 117 | 145 | 478 | 7350 | 1568 | 474 | 3.43 | 50.69 | 43.07 | |
14 | Expert Opinion on Investigational Drugs | journal | 1.166 Q1 | 117 | 137 | 398 | 10419 | 1361 | 387 | 3.58 | 76.05 | 38.63 | |
15 | Journal of Biomedical Science | journal | 1.302 Q1 | 110 | 95 | 289 | 6787 | 1043 | 289 | 3.55 | 71.44 | 41.67 | |
16 | Drugs and Aging | journal | 1.072 Q2 | 109 | 87 | 273 | 5126 | 806 | 263 | 2.66 | 58.92 | 44.82 | |
17 | Pharmacoepidemiology and Drug Safety | journal | 1.329 Q1 | 109 | 195 | 538 | 5867 | 1251 | 491 | 2.15 | 30.09 | 47.49 | |
18 | Expert Review of Neurotherapeutics | journal | 1.006 Q2 | 98 | 118 | 398 | 10360 | 1250 | 373 | 3.25 | 87.80 | 31.70 | |
19 | Trials | journal | 1.291 Q1 | 98 | 612 | 1682 | 23937 | 4021 | 1652 | 2.18 | 39.11 | 46.78 | |
20 | Antiviral Therapy | journal | 0.958 Q2 | 93 | 90 | 310 | 2579 | 664 | 299 | 2.04 | 28.66 | 43.42 | |
21 | Expert Opinion on Pharmacotherapy | journal | 0.909 Q2 | 93 | 207 | 732 | 14623 | 2161 | 707 | 3.10 | 70.64 | 37.35 | |
22 | CNS Neuroscience and Therapeutics | journal | 1.380 Q1 | 91 | 99 | 402 | 4502 | 1306 | 317 | 3.04 | 45.47 | 40.00 | |
23 | Expert Opinion on Drug Safety | journal | 1.112 Q1 | 90 | 139 | 510 | 9936 | 1737 | 490 | 3.31 | 71.48 | 42.56 | |
24 | HIV Medicine | journal | 1.394 Q1 | 86 | 101 | 287 | 2793 | 728 | 265 | 2.56 | 27.65 | 49.36 | |
25 | Human Psychopharmacology | journal | 1.128 Q1 | 86 | 69 | 170 | 2986 | 516 | 170 | 2.93 | 43.28 | 44.21 | |
26 | Expert Review of Anticancer Therapy | journal | 0.804 Q2 | 85 | 120 | 430 | 8365 | 856 | 403 | 2.10 | 69.71 | 34.73 | |
27 | Fundamental and Clinical Pharmacology | journal | 0.688 Q2 | 85 | 69 | 201 | 3327 | 454 | 200 | 2.26 | 48.22 | 44.44 | |
28 | Journal of Clinical Pharmacy and Therapeutics | journal | 0.722 Q2 | 81 | 128 | 358 | 3863 | 728 | 351 | 1.91 | 30.18 | 40.65 | |
29 | BioDrugs | journal | 1.038 Q2 | 79 | 45 | 131 | 3062 | 513 | 125 | 4.40 | 68.04 | 37.78 | |
30 | International Journal of STD and AIDS | journal | 0.737 Q2 | 78 | 218 | 554 | 5319 | 785 | 516 | 1.37 | 24.40 | 50.56 | |
31 | Paediatric Drugs | journal | 0.814 Q2 | 70 | 58 | 143 | 3378 | 372 | 136 | 2.41 | 58.24 | 51.53 | |
32 | Clinical Drug Investigation | journal | 0.719 Q2 | 67 | 113 | 296 | 4731 | 643 | 287 | 2.09 | 41.87 | 59.48 | |
33 | Antimicrobial Resistance and Infection Control | journal | 1.573 Q1 | 66 | 126 | 149 | 4237 | 557 | 145 | 3.75 | 33.63 | 42.62 | |
34 | Biopharmaceutics and Drug Disposition | journal | 0.551 Q2 | 65 | 50 | 148 | 1963 | 304 | 146 | 1.68 | 39.26 | 35.92 | |
35 | Expert Review of Pharmacoeconomics and Outcomes Research | journal | 0.738 Q2 | 61 | 63 | 278 | 3202 | 478 | 265 | 1.67 | 50.83 | 45.68 | |
36 | American Journal of Cardiovascular Drugs | journal | 0.951 Q2 | 60 | 47 | 128 | 2530 | 376 | 121 | 2.88 | 53.83 | 27.23 | |
37 | Expert Review of Clinical Pharmacology | journal | 0.833 Q2 | 60 | 127 | 314 | 10221 | 816 | 296 | 2.50 | 80.48 | 38.94 | |
38 | Journal of Cardiovascular Pharmacology and Therapeutics | journal | 1.272 Q1 | 57 | 64 | 175 | 3550 | 510 | 169 | 2.61 | 55.47 | 25.97 | |
39 | Journal of Chemotherapy | journal | 0.483 Q3 | 56 | 70 | 234 | 2058 | 296 | 214 | 1.27 | 29.40 | 39.84 | |
40 | Cardiovascular Therapeutics | journal | 1.075 Q2 | 54 | 71 | 154 | 2744 | 394 | 149 | 2.32 | 38.65 | 30.24 | |
41 | Expert Opinion on Emerging Drugs | journal | 1.109 Q1 | 54 | 28 | 129 | 3050 | 393 | 121 | 3.39 | 108.93 | 41.89 | |
42 | HIV Research and Clinical Practice | journal | 54 | 26 | 87 | 767 | 140 | 86 | 1.53 | 29.50 | 39.67 | ||
43 | European Journal of Contraception and Reproductive Health Care | journal | 0.642 Q2 | 53 | 77 | 184 | 2080 | 269 | 170 | 1.46 | 27.01 | 60.98 | |
44 | Therapeutic Advances in Respiratory Disease | journal | 1.081 Q2 | 50 | 38 | 100 | 1761 | 353 | 93 | 3.74 | 46.34 | 47.16 | |
45 | AIDS Research and Therapy | journal | 1.080 Q2 | 49 | 60 | 124 | 2461 | 304 | 123 | 2.47 | 41.02 | 43.12 | |
46 | npj Vaccines | journal | 2.269 Q1 | 47 | 34 | 16 | 1814 | 46 | 15 | 2.88 | 53.35 | 39.78 | |
47 | Advances in Pharmacological and Pharmaceutical Sciences | journal | 46 | 5 | 70 | 447 | 173 | 70 | 2.58 | 89.40 | 20.83 | ||
48 | npj Breast Cancer | journal | 46 | 48 | 40 | 2007 | 146 | 37 | 3.65 | 41.81 | 50.68 | ||
49 | Pharmaceutical Statistics | journal | 1.494 Q1 | 46 | 39 | 158 | 1037 | 192 | 153 | 0.92 | 26.59 | 30.00 | |
50 | Therapeutic Advances in Drug Safety | journal | 1.494 Q1 | 46 | 35 | 71 | 1424 | 333 | 52 | 2.56 | 40.69 | 43.62 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®